On August 31, 2026 Olema Pharmaceuticals, Inc. ("Olema" or "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, reported that the Company will participate in the following upcoming investor conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Citi 2026 Biopharma Back to School Conference
Date and Time: September 10, 2026 at 1 p.m. ET
Format: Fireside Chat
Location: New York, NY
Morgan Stanley 24th Annual Global Healthcare Conference
Date and Time: September 15, 2026 at 1:50 p.m. ET
Format: Fireside Chat
Location: New York, NY
H.C. Wainwright 28th Annual Global Investment Conference
Date and Time: September 16, 2026 at 9:30 a.m. ET
Format: Fireside Chat
Location: New York, NY
Live webcasts and recordings of these presentations will be available, as permitted by the event host, in the Events and Presentations section of Olema’s investor relations website at ir.olema.com.
(Press release, Olema Oncology, AUG 31, 2026, View Source [SID1234670474])